Ori­gi­nal-Re­se­arch: CENIT AG (by GBC AG): Buy

Re­se­arch | 5 Au­gust 2026 09:30

Ori­gi­nal-Re­se­arch: CENIT AG – by GBC AG

05.08.2026 / 09:30 CET/CEST
Dis­se­mi­na­ti­on of a Re­se­arch, trans­mit­ted by EQS News – a ser­vice of EQS Group.
The is­suer is so­le­ly re­spon­si­ble for the con­tent of this re­se­arch. The re­sult of this re­se­arch does not con­sti­tu­te in­vest­ment ad­vice or an in­vi­ta­ti­on to con­clude cer­tain stock ex­ch­an­ge tran­sac­tions.


Clas­si­fi­ca­ti­on of GBC AG to CENIT AG

Com­pa­ny Name: CENIT AG
ISIN: DE0005407100
Re­ason for the re­se­arch: Re­se­arch Com­ment
Re­com­men­da­ti­on: BUY
Tar­get pri­ce: EUR 14.15
Tar­get pri­ce on sight of: 31.12.2027
Last ra­ting ch­an­ge:
Ana­lyst: Cos­min Fil­ker; Mar­cel Gold­mann

Strong rise in ear­nings 1 HY 2026; Ca­pi­tal in­crease se­cu­red for the ac­qui­si­ti­on of ISR; Lower PT of €14.15 fol­lo­wing ca­pi­tal in­crease

Whilst CENIT AG had achie­ved a slight in­crease in tur­no­ver of 1.9% to €52.47 mil­li­on in the first quar­ter, tur­no­ver in the se­cond quar­ter, at €52.19 mil­li­on, was al­most exact­ly on a par with the pre­vious year (Q2 25: €52.20 mil­li­on). In the first six months of 2026, the com­pa­ny thus ge­ne­ra­ted re­ve­nue of €104.66 mil­li­on (pre­vious year: €103.71 mil­li­on), re­pre­sen­ting a mar­gi­nal in­crease of 0.9%. This de­ve­lo­p­ment is in line with ex­pec­ta­ti­ons, par­ti­cu­lar­ly against the back­drop of the full-year re­ve­nue fo­re­cast of €210 mil­li­on pro­vi­ded by ma­nage­ment, which would re­pre­sent a flat trend com­pared with the pre­vious year’s re­ve­nue (2025: €209.51 mil­li­on).

Along­side the rise in high-mar­gin re­ve­nue, the com­pa­ny be­ne­fi­ted from the cost-sa­ving me­a­su­res im­ple­men­ted. In par­ti­cu­lar, the re­duc­tion in the work­force car­ri­ed out as part of the ‘Pro­ject Per­for­mance’ res­truc­tu­ring pro­gram­me led to a no­ti­ceable de­cli­ne in staff cos­ts to €46.72 mil­li­on (pre­vious year: €52.30 mil­li­on). De­spi­te the slight growth in tur­no­ver, EBITDA im­pro­ved si­gni­fi­cant­ly to €8.52 mil­li­on (pre­vious year: €1.20 mil­li­on). This mark­ed a new half-year re­cord. The EBITDA mar­gin of 8.1 per cent (pre­vious year: 1.2 per cent) is in line with his­to­ri­cal le­vels from be­fo­re the Ke­onys ac­qui­si­ti­on, when the com­pa­ny re­por­ted a si­gni­fi­cant­ly lower pro­por­ti­on of lower-mar­gin tra­ding re­ve­nue.

On 7 July 2026, the com­pa­ny an­noun­ced a plan­ned ca­pi­tal in­crease, for which the sub­scrip­ti­on of­fer com­men­ced on 3 Au­gust 2026. As part of the ca­pi­tal in­crease, 1.67 mil­li­on new shares are be­ing of­fe­red, re­pre­sen­ting 20% of the cur­rent share ca­pi­tal. Ac­cor­din­gly, the sub­scrip­ti­on ra­tio is 5:1, and the sub­scrip­ti­on pri­ce per share is €6.50. The gross pro­ceeds from the is­sue amount to €10.88 mil­li­on. The ma­jo­ri­ty share­hol­der, PRIMEPULSE SE, has pro­vi­ded a writ­ten un­der­ta­king to exer­cise its sub­scrip­ti­on rights in full and to ac­qui­re any shares not ta­ken up by the other share­hol­ders. In ef­fect, this se­cu­res the ca­pi­tal in­crease.

The pro­ceeds are to be used to ac­qui­re the out­stan­ding 25.1% sta­ke in ISR In­for­ma­ti­on Pro­ducts AG (ISR). No spe­ci­fic purcha­se pri­ce is gi­ven, but it is in the low dou­ble-di­git mil­li­ons. ISR, which is al­lo­ca­ted to the EIM seg­ment, was ac­qui­red in the 2022 fi­nan­cial year. €27.88 mil­li­on was paid for the in­iti­al 74.9% sta­ke. Agree­ments were also in place for the ac­qui­si­ti­on of the re­mai­ning shares. Sin­ce 1 April 2026, the ISR mi­no­ri­ty share­hol­ders have been able to exer­cise their put op­ti­on (a short put op­ti­on from CENIT AG’s per­spec­ti­ve), ther­eby crea­ting a purcha­se ob­li­ga­ti­on for CENIT AG. In our view, the mi­no­ri­ty share­hol­ders have exer­cis­ed this op­ti­on.

Ac­cor­ding to the an­nu­al re­port for the 2025 fi­nan­cial year, ISR ge­ne­ra­ted a pro­fit af­ter tax of €3.45 mil­li­on in 2025. On a pro rata ba­sis, this re­pre­sen­ted mi­no­ri­ty in­te­rests of €0.87 mil­li­on. As a re­sult of the full ac­qui­si­ti­on, CENIT’s pro­fit af­ter tax is the­r­e­fo­re li­kely to be ap­pro­xi­m­ate­ly €1.0 mil­li­on hig­her an­nu­al­ly in fu­ture. Ba­sed on the purcha­se pri­ce in the low dou­ble-di­git mil­li­ons, which we as­su­me is rough­ly in line with the le­vel of the ca­pi­tal in­crease, this re­sults in a cal­cu­la­ted P/E ra­tio of 11.

With the pu­bli­ca­ti­on of its half-year re­sults for 2026, CENIT AG has also con­firm­ed its fo­re­cast for the cur­rent fi­nan­cial year 2026. The com­pa­ny con­ti­nues to ex­pect con­so­li­da­ted tur­no­ver of at least €210 mil­li­on and EBITDA of at least €18.0 mil­li­on. Ba­sed on the fi­gu­res achie­ved in the first half of the year, the con­firm­ed fo­re­cast ap­pears high achie­va­ble. Whilst, in terms of re­ve­nue, more than 50% of the full-year re­ve­nue tar­get was al­re­a­dy achie­ved in the first six months, a fur­ther in­crease in ear­nings would need to be rea­li­sed in the se­cond half of the year. Gi­ven the company’s ty­pi­cal dis­tri­bu­ti­on of re­ve­nue and ear­nings, with the fo­cus on the fi­nal quar­ter of the year, we con­sider the li­keli­hood of mee­ting the tar­gets to be very high.

We the­r­e­fo­re con­firm our esti­ma­tes, which are al­re­a­dy slight­ly abo­ve the mi­ni­mum fi­gu­res com­mu­ni­ca­ted in the gui­dance. We ex­pect re­ve­nue of €214.74 mil­li­on and EBITDA of €19.13 mil­li­on. We have also left our fo­re­casts for the co­ming fi­nan­cial ye­ars un­ch­an­ged. Ho­we­ver, the­re are ch­an­ges in terms of pro­fit af­ter tax, which take into ac­count the eli­mi­na­ti­on of mi­no­ri­ty in­te­rests for ISR In­for­ma­ti­on Pro­ducts AG. We ex­pect the tran­sac­tion to be com­ple­ted in the fourth quar­ter of 2026, mea­ning that the im­pact on pro­fit af­ter tax in this fi­nan­cial year will re­main li­mi­t­ed. From the co­ming fi­nan­cial year on­wards, we an­ti­ci­pa­te the eli­mi­na­ti­on of mi­no­ri­ty in­te­rests amoun­ting to ap­pro­xi­m­ate­ly €1.0 mil­li­on per year. We have ta­ken this into ac­count ac­cor­din­gly in our esti­ma­tes of pro­fit af­ter tax for the co­ming fi­nan­cial ye­ars. Ho­we­ver, the di­lu­ti­on ef­fect re­sul­ting from the hig­her num­ber of shares is ac­com­pa­nied by lower ear­nings per share.

As part of our DCF va­lua­ti­on mo­del, we have de­ter­mi­ned a new tar­get pri­ce of €14.15 per share (pre­vious­ly: €16.00). The de­cli­ne in the tar­get pri­ce is al­most ex­clu­si­ve­ly at­tri­bu­ta­ble to the di­lu­ti­on ef­fect as­so­cia­ted with the ca­pi­tal in­crease. Alt­hough we have cal­cu­la­ted a hig­her en­ter­pri­se va­lue of €142.07 mil­li­on (pre­vious­ly: €133.90 mil­li­on), this is spread across 10.04 mil­li­on shares (pre­vious­ly: 8.37 mil­li­on shares). The ca­pi­tal in­crease and the pay­ment of the purcha­se pri­ce are li­kely to re­sult in a slight net re­duc­tion in cash and cash equi­va­lents. Ho­we­ver, the roll-over ef­fect (new tar­get pri­ce ho­ri­zon: 30 June 2027) has led to an in­crease in fair va­lue. This has even off­set the va­lue-re­du­cing ef­fect of the rise in the risk-free in­te­rest rate to 3.5% (pre­vious­ly: 3.0%). We are main­tai­ning our ‘BUY’ ra­ting.

You can down­load the re­se­arch here: 20260805_CENIT_Comment_engl

Cont­act for ques­ti­ons:
GBC AG
Hal­der­stra­ße 27
86150 Augs­burg
0821241133 0
research@​gbc-​ag.​de
++++++++++++++++
Dis­clo­sure of po­ten­ti­al con­flicts of in­te­rest pur­su­ant to Sec­tion 85 WpHG and Art. 20 MAR The com­pa­ny ana­ly­sed abo­ve has the fol­lo­wing po­ten­ti­al con­flict of in­te­rest: (5a,6a,7,11); A ca­ta­lo­gue of po­ten­ti­al con­flicts of in­te­rest can be found at: https://​www​.gbc​-ag​.de/​d​e​/​O​f​f​e​n​l​e​g​u​n​g​.​htm
+++++++++++++++
Date (time) Com­ple­ti­on: 05.08.2026 (08:03 am)
Date (time) first trans­mis­si­on: 05.08.2026 (9:30 am)

Cont­act

Stu­dies

GBC AG
Hal­der­stra­ße 27
86150 Augs­burg

Te­le­fon: +49 821 241133–0
E‑mail: office(@)gbc-ag.de